Concordia Drug Patent Portfolio
Concordia owns 2 orange book drugs protected by 3 US patents Given below is the list of Concordia's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6149940 | Tablet with controlled release of alfuzosine chlorhydrate | 22 Feb, 2018 | Expired |
| US6149940 | Tablet with controlled release of alfuzosine chlorhydrate | 22 Aug, 2017 | Expired |
| US5932622 | Method for in vivo modulation of non-malignant skin-related processes with 9-cis-retinoic acid | 03 Aug, 2016 | Expired |
Concordia's Family Patents
Concordia Drug List
Given below is the complete list of Concordia's drugs and the patents protecting them.
1. Panretin
Panretin is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5932622 | Method for in vivo modulation of non-malignant skin-related processes with 9-cis-retinoic acid |
03 Aug, 2016
(8 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Panretin's drug page
2. Uroxatral
Uroxatral is protected by 2 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6149940
(Pediatric)
| Tablet with controlled release of alfuzosine chlorhydrate |
22 Feb, 2018
(6 years ago)
| Expired |
| US6149940 | Tablet with controlled release of alfuzosine chlorhydrate |
22 Aug, 2017
(7 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Uroxatral's drug page